← Leaderboards
Nicholas A Carpino
St. Jude Children'S Research Hospital
$5,610,017
Attributed
$8,752,989
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.1M · FY2007–25$5M$3.8M$2.5M$1.3M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,752,989 · 7
By mechanism
R01$7,395,926 · 3
R21$1,303,098 · 3
F32$53,965 · 1
Top collaborators
- Jarrod B French5 shared
- Louis Daniel Scampavia4 shared
Most similar at St. Jude Children'S Research Hospital
Same institution · by research overlap
- Yongqiang Feng$5,614,144
- Brenda A Schulman$8,396,361
- Yong Cheng$4,365,040
Others in their field
Top investigators on “Immune Response”
- Lawrence Corey · Fred Hutchinson Cancer Center$680,290,567
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$542,695,345
- Barton F Haynes · Duke University$456,664,915
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$309,708,725
- Peter B. Gilbert · Fred Hutchinson Cancer Center$192,329,665
Research focus
Immune ResponsePhenotypePhosphoric Monoester HydrolasesPathogenResponseEnzymesProteinsSignal PathwayCellsStructureImmune SystemPlayEnzyme ActivityBiologicalCytokinePreventPredispositionMouse ModelPhosphorylationProductionInfectionPropertyPeripheralPathology
Grant awards (18)
Optimizing anti-microbial immunity by targeting Sts-1$3,125,627
R01 · FY2025 · AI · contact PI
Optimizing the immune response by targeting the Sts enzymes$563,489
R01 · FY2022 · AI · contact PI
Optimizing the immune response by targeting the Sts enzymes$604,227
R01 · FY2021 · AI · contact PI
Optimizing the immune response by targeting the Sts enzymes$572,094
R01 · FY2020 · AI · contact PI
Optimizing the immune response by targeting the Sts enzymes$630,428
R01 · FY2019 · AI · contact PI
Role of Sts-1 and -2 in the host response to bacterial pathogens$232,781
R21 · FY2019 · AI · contact PI
Establishing Sts-1 as a novel target for treatment of systemic candidiasis$198,904
R21 · FY2019 · AI · contact PI
Establishing Sts-1 as a novel target for treatment of systemic candidiasis$256,959
R21 · FY2018 · AI · contact PI
Role of Sts-1 and -2 in the host response to bacterial pathogens$192,621
R21 · FY2018 · AI · contact PI
Regulation of TCR Signaling by Sts-1 and Sts-2$384,128
R01 · FY2014 · AI · contact PI
Regulation of TCR Signaling by Sts-1 and Sts-2$361,081
R01 · FY2013 · AI · contact PI
Regulation of TCR Signaling by Sts-1 and Sts-2$384,128
R01 · FY2012 · AI · contact PI
Regulation of TCR Signaling by Sts-1 and Sts-2$384,128
R01 · FY2011 · AI · contact PI
Regulation of TCR Signaling by Sts-1 and Sts-2$386,596
R01 · FY2010 · AI · contact PI
Regulation of TCR signaling by a novel enzyme activity.$228,083
R21 · FY2008 · AI · contact PI
Regulation of TCR signaling by a novel enzyme activity.$193,750
R21 · FY2007 · AI · contact PI
JAK2 MEDIATED SIGNAL TRANSDUCTION$16,449
F32 · FY2001 · CA
JAK2 MEDIATED SIGNAL TRANSDUCTION$37,516
F32 · FY2000 · CA